James Pallotta reports 5.2% stake in TriSalus Life Sciences (TLSI)

Rhea-AI Filing Summary

TriSalus Life Sciences disclosed beneficial ownership for James J. Pallotta. The amendment to Schedule 13G/A shows Mr. Pallotta beneficially owns 3,188,711 shares, equal to 5.2% of common stock based on May 8, 2026, and that this total includes 114,268 shares underlying warrants exercisable into common stock. The filing lists the issuer address as 6272 W. 91st Ave., Westminster, CO 80031 and is signed by James J. Pallotta on May 20, 2026.

Insights

Corporate Governance Analyst

Disclosure records a non‑controlling but notable 5.2% position by an individual holder.

Mr. Pallotta is reported to beneficially own 3,188,711 shares including 114,268 shares tied to exercisable warrants, using the issuer's outstanding share base as of May 8, 2026. The filing is an amendment to a Schedule 13G, a passive ownership disclosure.

The practical implication is disclosure of a 5.2% stake; timing and any plans for trading are not included in the excerpt. Subsequent filings would show changes if the holder trades or files a different reporting schedule.

Key Figures

Beneficial ownership: 3,188,711 shares Ownership percentage: 5.2% Warrants exercisable: 114,268 shares +1 more

4 metrics

Beneficial ownership 3,188,711 shares reported by James J. Pallotta

Ownership percentage 5.2% calculated as of <date>May 8, 2026</date>

Warrants exercisable 114,268 shares included in reported ownership total

Shares outstanding used 61,416,535 shares issuer's common stock outstanding as of <date>May 8, 2026</date>

Key Terms

Schedule 13G/A, beneficially owned, warrants exercisable

3 terms

Schedule 13G/A regulatory

"Amendment No. 1; passive beneficial ownership report"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

beneficially owned financial

"Amounts reported include ... shares underlying warrants exercisable"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

warrants exercisable financial

"114,268 shares underlying warrants exercisable into shares"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/20/2026 - 04:10 PM Learn about SEC filing dates

FAQ

What stake does James J. Pallotta report in TriSalus (TLSI)?

He reports beneficial ownership of 3,188,711 shares, representing 5.2% of common stock based on the issuer's outstanding shares as of May 8, 2026. This total includes 114,268 shares underlying exercisable warrants.

Does the filing include derivative holdings for TLSI?

Yes. The filing states the reported total includes 114,268 shares underlying warrants exercisable into common stock, counted in the 5.2% ownership calculation using the May 8, 2026 share base.

What document was amended to report this ownership for TLSI?

This disclosure appears as Amendment No. 1 to a Schedule 13G/A, indicating an amended passive beneficial‑ownership report signed by James J. Pallotta on May 20, 2026.

How was the 5.2% ownership percentage calculated?

The percentage is calculated using 61,416,535 shares outstanding as of May 8, 2026 per the issuer's Form 10‑Q, plus the 114,268 exercisable warrant shares included in Mr. Pallotta's reported total.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

TriSalus Life Sciences, Inc.

(Name of Issuer)

Common Stock, Par Value $0.0001 per share

(Title of Class of Securities)

89680M101

(CUSIP Number)

05/15/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 89680M101

1

Names of Reporting Persons

James J. Pallotta

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 3,188,711.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 3,188,711.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,188,711.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.2 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: Amounts reported include 114,268 shares underlying warrants exercisable into shares of the issuer's common stock. The percentage reported is calculated based upon 61,416,535 shares of the issuer's common stock outstanding as of May 8, 2026, as reported in the issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 12, 2026, plus 114,268 shares underlying warrants exercisable into shares of the issuer's common stock.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: TriSalus Life Sciences, Inc.
(b)	Address of issuer's principal executive offices: 6272 W. 91st Ave., Westminster, CO 80031
Item 2.
(a)	Name of person filing: James J. Pallotta
(b)	Address or principal business office or, if none, residence: 2340 Collins Ave., 5th Floor, Miami Beach, FL 33139
(c)	Citizenship: United States of America
(d)	Title of class of securities: Common Stock, Par Value $0.0001 per share
(e)	CUSIP No.: 89680M101
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See Row 9 of the cover page.
(b)	Percent of class: See Row 11 of the cover page.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See Row 5 of the cover page.
	(ii) Shared power to vote or to direct the vote: See Row 6 of the cover page.
	(iii) Sole power to dispose or to direct the disposition of: See Row 7 of the cover page.
	(iv) Shared power to dispose or to direct the disposition of: See Row 8 of the cover page.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

James J. Pallotta

Signature:	/s/ James J. Pallotta
Name/Title:	James J. Pallotta
Date:	05/20/2026